Organ Transplantation

Subscribe to Selected New Research on Organ Transplantation

2370 relevant articles (74 outcomes, 104 trials/studies) found for this Therapy

Description: Transference of an organ between individuals of the same species or between individuals of different species.

Also Known As:

Graftings, Organ; Organ Grafting; Organ Graftings; Organ Transplantations; Transplantations, Organ; Grafting, Organ; Transplantation, Organ

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36585

Organ Transplantation: 2370

Liver Transplantation: 12387

Kidney Transplantation: 9588

Heart Transplantation: 5054

Lung Transplantation: 2851

Bone Transplantation: 1264

Pancreas Transplantation: 591

Facial Transplantation: 11

Experts

1.	Centers for Disease Control and Prevention (CDC): 5 articles (07/2006 - 03/2002)
2.	Margreiter, R: 3 articles (11/2007 - 01/2000)
3.	Oertel, Stephan: 3 articles (08/2007 - 07/2006)
4.	Green, M: 3 articles (06/2001 - 02/2000)
5.	Subramanian, Aruna K: 2 articles (09/2008 - 08/2008)
6.	Wittwer, Thorsten: 2 articles (01/2008 - 07/2002)
7.	Moreno, A: 2 articles (01/2008 - 11/2005)
8.	Wahlers, Thorsten: 2 articles (01/2008 - 07/2002)
9.	Riess, Hanno: 2 articles (08/2007 - 07/2006)
10.	Dörken, Bernd: 2 articles (08/2007 - 07/2006)

Related Diseases

1.	Autoimmune Diseases (Autoimmune Disease) 01/01/1986 - "The present findings demonstrate that MX is a potent immunosuppressive agent and as such might prove to be clinically useful in the treatment of autoimmune diseases or find utility in the organ transplantation field." 01/01/2005 - "Immunosuppressive drugs have improved the therapeutic management of allograft organ transplantation and autoimmune diseases, significantly" 01/01/2004 - "Immunosuppressive drugs have revolutionized organ transplantation and improved the therapeutic management of autoimmune diseases" 02/01/1987 - "New information about established immunosuppressive drugs and the introduction of new drugs are providing new opportunities for effective treatment of autoimmune diseases and improved effectiveness of organ transplantation" 05/01/2002 - "Pharmacogenomics holds many promises for improved treatment of a large variety of medical conditions, including immunosuppression for organ transplantation and autoimmune disease" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 01/01/2007 - "A rise in GSH level is beneficial in all pathological states, accompanied by lowered GSH content, while a lowering of GSH level is an indication to induce short-term immunosuppression required in organ transplantation and in tumor cells to selectively increase their sensitivity to chemo- and radiotherapy" 05/01/1993 - "Transfusion-induced immunosuppression has long been known to be beneficial for organ transplantation patients, but recent retrospective studies suggest that blood transfusions may be detrimental for patients with cancer" 01/01/2000 - "The efficacy of adjuvant cytostatic therapy after organ transplantation for malignancy: an experimental study with a combined transplantation/tumor model." 11/01/2008 - "Increased cancer incidence after organ transplantation is well documented but few studies have reported on the rate of head and neck malignancies among these patients" 05/01/2007 - "The aim of this study was to characterize distribution and appearance of abdominal malignant tumors detected with spiral computed tomography (CT) examination in patients with solid organ transplantation" Get all the results and reference details, order at left...
3.	Infection 01/01/1995 - "For patients becoming partially immunocompromised following solid organ transplantation, protection against severe CMV disease is afforded by immunity acquired either by wild-type infection prior to transplantation or passive or active immunization" 02/01/2008 - "Although rare, HSV-2-disseminated infection, in the context of organ transplantation may be life-threatening, but can be cured if ACV therapy is initiated early in the course of this disease." 01/01/1998 - "Recent developments in diagnosis and therapy of cytomegalovirus (CMV) infection have helped to reduce CMV-associated mortality following organ transplantation" 01/01/2008 - "Because most nonhuman primate studies in organ transplantation are quite small, there are only a few published reports concerning infections after transplantation in nonhuman primates" 08/01/2007 - "Nevertheless, organ transplantation in HIV-infected patients remains a complex intervention, and more studies will be required to clarify open questions such as long-term effects of drug interactions between antiretroviral and immunosuppressive drugs, outcome of recurrent HCV infection in HIV-infected patients, incidence of graft rejection, or long-term graft and patient survival" Get all the results and reference details, order at left...
4.	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/01/2006 - "Post-transplant lymphoproliferative disorders (PTLD) are severe complications after solid organ transplantation with no consensus on best treatment practice" 08/15/2006 - "Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation." 07/01/1994 - "PURPOSE: To study the histopathologic findings, clinical course, and therapeutic outcome of patients who developed a lymphoproliferative disorder after undergoing solid organ transplantation" 10/01/2008 - "BACKGROUND: Posttransplantation lymphoproliferative disorder (PTLD) involving the central nervous system (CNS) is a rare and serious complication associated with solid organ transplantation" 10/01/2008 - "Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after solid-organ transplantation" Get all the results and reference details, order at left...
5.	Graft vs Host Disease (Graft-Versus-Host Disease) 12/01/2003 - "These MoAbs have been used effectively in preventing and/or treating rejection in solid organ transplantation and are currently under investigation for prevention/treatment of graft-versus-host disease (GvHD) in stem cell transplantation" 05/29/2001 - "An advantageous feature of TLI for combined marrow and organ transplantation is the protection against graft-versus-host disease (GVHD) and facilitation of chimerism afforded by the predominance of CD4+ NK1.1(+) -like T cells in the irradiated host lymphoid tissues" 11/01/2008 - "Acute graft-versus-host disease (GvHD) is a rare complication after solid organ transplantation" 11/01/2008 - "Acute graft-versus-host disease (aGVHD) is a life-threatening complication after solid-organ transplantation, which is mediated by host-reactive donor T cells emigrating from the allograft" 10/01/2008 - "BACKGROUND: Passenger lymphocyte-mediated graft-versus-host disease (GVHD) in solid organ transplantation (SOT-GVHD) is considered a rare complication, particularly among recipients of lung allografts" Get all the results and reference details, order at left...
479 Diseases and 2370 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Methoxsalen (Oxsoralen)
3.	rituximab (Mabthera)
4.	Tacrolimus (Prograf)
5.	Antibodies
6.	Carboplatin (JM8)
7.	Calcineurin
8.	Antigens
9.	Ganciclovir (Cytovene)
10.	Paclitaxel (Taxol)
245 Drugs and Important Bio-Agents and 494 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Transplantation (Transplant Recipients)
3.	Homologous Transplantation (Allograft)
4.	Drug Therapy (Chemotherapy)
5.	Stem Cell Transplantation
75 Therapies and Procedures and 582 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>